Worth reading
47Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
2440000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Fifth Series Stock Acquisition Rights Issued through Third-Party Allotment (with Exercise Price Adjustment Clause)
発行・処分する株式数
Shares delivered during the month: 2,440,000 shares. New shares: 2,440,000 shares; treasury shares transferred: 0 shares
Intended allottee
EVO FUND (allottee at the time of issuance)
発行済株式総数
Exercise ratio subject to exercise restrictions: 2.1% (①2,440,000 shares / ②114,860,220 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price during the month: ¥71–¥115. Details of the adjustment clause: Not disclosed
Number of Stock Acquisition Rights
Total issued: 280,000 rights. Unexercised as of 14 October 2026: 280,000 rights. Exercised during the month: 24,400 rights. Unexercised at month-end: 255,600 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Issued on 14 October 2026: Fifth Series Stock Acquisition Rights through third-party allotment (with exercise price adjustment clause) and First Series Unsecured Corporate Bonds (privately placed)
| Item | Details |
|---|---|
| Type of issuance or disposal | Fifth Series Stock Acquisition Rights Issued through Third-Party Allotment (with Exercise Price Adjustment Clause) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 2,440,000 shares. New shares: 2,440,000 shares; treasury shares transferred: 0 shares |
| Intended allottee | EVO FUND (allottee at the time of issuance) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 2.1% (①2,440,000 shares / ②114,860,220 shares) |
| Total number of issued shares | 114,860,220 shares (as of 14 October 2026) → Not disclosed |
| Exercise price | Exercise price during the month: ¥71–¥115. Details of the adjustment clause: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 280,000 rights. Unexercised as of 14 October 2026: 280,000 rights. Exercised during the month: 24,400 rights. Unexercised at month-end: 255,600 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Issued on 14 October 2026: Fifth Series Stock Acquisition Rights through third-party allotment (with exercise price adjustment clause) and First Series Unsecured Corporate Bonds (privately placed) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the Fifth Series Stock Acquisition Rights for October 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.